文献速递肝病消化道出血

卡维地洛预防性治疗肝硬化食管静脉曲张患者的无创应答预测

Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.
PubMed 文献 · J Hepatol · 2018-10-31

该前瞻性队列研究纳入106例高风险食管静脉曲张肝硬化患者(推导队列)接受卡维地洛预防,在剂量滴定前后测量肝静脉压力梯度、肝硬度(LS)与脾硬度(SS),建立基于ΔSS的应答预测模型并在63例验证队列中外部验证。推导队列血流动力学应答55.7%、验证队列52.4%,ΔSS为唯一显著预测因子(OR 0.039,95%CI 0.008-0.135,P<0.0001),模型AUC推导0.803、验证0.848(阈值0.530)。

要点

  • ΔSS是卡维地洛血流动力学应答的唯一显著预测因子(OR 0.039,95%CI 0.008-0.135,P<0.0001)。
  • 基于ΔSS的预测模型阈值0.530,推导队列AUC 0.803,验证队列AUC 0.848。
  • 推导队列应答率55.7%(59/106),验证队列52.4%(33/63)。

核心结论

  • 基于脾硬度动态变化的新模型在预测高风险食管静脉曲张患者对非选择性β受体阻滞剂预防的血流动力学应答方面表现良好。

研究设计与样本

  • 前瞻性队列研究,推导队列106例高风险食管静脉曲张肝硬化患者接受卡维地洛预防,并在剂量滴定开始与结束时完成配对肝静脉压力梯度、肝硬度(LS)和脾硬度(SS)测量;LS和SS采用声辐射力脉冲成像测量;衍生预测模型并在验证队列63例患者中外部验证。

主要发现

  • 推导队列59例(55.7%)发生血流动力学应答,验证队列33例(52.4%)发生应答。
  • 多因素logistic回归分析确定ΔSS是血流动力学应答的唯一显著预测因子(OR 0.039,95%CI 0.008-0.135,P<0.0001)。
  • 应答预测模型ModelΔSS=0.0490-2.8345×ΔSS;评分=(exp[ModelΔSS])/(1+exp[ModelΔSS]),以0.530为阈值时推导队列AUC=0.803。
  • ModelΔSS在验证集中使用相同阈值时预测性能提高(AUC=0.848)。

关键数值与推荐

  • ΔSS的OR为0.039(95%CI 0.008-0.135,P<0.0001)。
  • 预测模型阈值取0.530,推导队列AUC=0.803,验证队列AUC=0.848。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Non-selective beta-blockers (NSBBs) are the mainstay of primary prophylaxis of esophageal variceal bleeding in patients with liver cirrhosis. We investigated whether non-invasive markers of portal hypertension correlate with hemodynamic responses to NSBBs in cirrhotic patients with esophageal varices. METHODS: In this prospective cohort study, 106 cirrhotic patients with high-risk esophageal varices in the derivation cohort received carvedilol prophylaxis, and completed paired measurements of hepatic venous pressure gradient, liver stiffness (LS), and spleen stiffness (SS) at the beginning and end of dose titration. LS and SS were measured using acoustic radiation force impulse imaging. A prediction model for hemodynamic response was derived, and subject to an external validation in the validation cohort (63 patients). RESULTS: Hemodynamic response occurred in 59 patients (55.7%) in the derivation cohort, and in 33 patients (52.4%) in the validation cohort, respectively. Multivariate logistic regression analysis identified that ΔSS was the only significant predictor of hemodynamic response (odds ratio 0.039; 95% confidence interval 0.008-0.135; p <0.0001). The response prediction model (ModelΔSS = 0.0490-2.8345 × ΔSS; score = (exp[ModelΔSS])/(1 + exp[ModelΔSS]) showed good predictive performance (area under the receiver-operating characteristic curve [AUC] = 0.803) using 0.530 as the threshold value. The predictive performance of the ModelΔSS in the validation set improved using the same threshold value (AUC = 0.848). CONCLUSION: A new model based on dynamic changes in SS exhibited good performance in predicting hemodynamic response to NSBB prophylaxis in patients with high-risk esophageal varices. LAY SUMMARY: Non-selective beta-blockers are the mainstay of primary prophylaxis to prevent variceal bleeding in patients with cirrhosis and high-risk esophageal varices. This prospective study showed that a prediction model based on changes in spleen stiffness before vs. after dose titration might be a non-invasive marker for response to prophylactic non-selective beta-blocker (carvedilol) therapy in patients with cirrhosis and high-risk esophageal varices. ClinicalTrials.gov Identifier: NCT01943318.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Kim HY, So YH, Kim W, et al. Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices. J Hepatol. 2018. PMID: 30389550. doi:10.1016/j.jhep.2018.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。